Nrgntm1Sut
Targeted Allele Detail
|
|
| Symbol: |
Nrgntm1Sut |
| Name: |
neurogranin; targeted mutation 1, J Gregor Sutcliffe |
| MGI ID: |
MGI:3628817 |
| Synonyms: |
RC3-beta-Gal |
| Gene: |
Nrgn Location: Chr9:37455789-37464041 bp, - strand Genetic Position: Chr9, 20.78 cM
|
| Alliance: |
Nrgntm1Sut page
|
|
| Germline Transmission: |
Earliest citation of germline transmission:
J:109224
|
| Parent Cell Line: |
J1 (ES Cell)
|
| Strain of Origin: |
129S4/SvJae
|
|
| Allele Type: |
|
Targeted (Null/knockout, Reporter) |
| Mutation: |
|
Insertion
|
| |
|
Mutation details: A targeting vector was designed to insert lacZ into exon 2 in frame such that a fusion protein would be expressed under the control of the endogenous promoter. The resulting protein consists of the first 30 residues of neurogranin followed by beta-gal sequence. The fusion protein does not contain the target of protein kinase C phosphorylation (Ser36) or residues required for binding to calmodulin.
(J:109224)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Nrgn Mutation: |
8 strains or lines available
|
|
| Original: |
J:109224 Krucker T, et al., Targeted disruption of RC3 reveals a calmodulin-based mechanism for regulating metaplasticity in the hippocampus. J Neurosci. 2002 Jul 1;22(13):5525-35 |
| All: |
1 reference(s) |
|